Akira Nishida
Overview
Explore the profile of Akira Nishida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshimura K, Shima A, Kambe D, Furukawa K, Nishida A, Wada I, et al.
Eur J Neurol
. 2024 Dec;
32(1):e70022.
PMID: 39716907
Background: A dual-syndrome hypothesis, which states the cognitive impairments in Parkinson's disease (PD) are attributable to frontostriatal dopaminergic dysregulation and cortical disturbance-each associated with attention/executive and memory/visuospatial dysfunction, respectively-has been...
2.
Kopitha K, Elakneswaran Y, Kitagaki R, Saito R, Yano K, Yoda Y, et al.
Sci Total Environ
. 2024 Nov;
957:177463.
PMID: 39528209
The escalating issue of global warming, driven by the surge in CO emissions, necessitates innovative strategies for reducing CO emissions. A novel approach is explored in this study, where amines...
3.
Sakato Y, Shima A, Terada Y, Takeda K, Sakamaki-Tsukita H, Nishida A, et al.
Brain
. 2024 Oct;
147(11):3702-3713.
PMID: 39445741
The clinical manifestation of Parkinson's disease exhibits significant heterogeneity in the prevalence of non-motor symptoms and the rate of progression of motor symptoms, suggesting that Parkinson's disease can be classified...
4.
Sakamaki-Tsukita H, Shima A, Kambe D, Furukawa K, Nishida A, Wada I, et al.
Parkinsonism Relat Disord
. 2024 Sep;
128:107134.
PMID: 39293154
Introduction: Magnetic resonance imaging (MRI)-determined atrophy of the nucleus basalis of Meynert (Ch4) predicts cognitive decline in Parkinson's disease (PD). However, interactions with other brain regions causing the decline remain...
5.
Nishida A, Shima A, Kambe D, Furukawa K, Sakamaki-Tsukita H, Yoshimura K, et al.
Neurology
. 2024 Jul;
103(3):e209606.
PMID: 38976821
Background And Objectives: Neural computations underlying gait disorders in Parkinson disease (PD) are multifactorial and involve impaired expression of stereotactic locomotor patterns and compensatory recruitment of cognitive functions. This study...
6.
Furukawa K, Shima A, Kambe D, Nishida A, Wada I, Sakamaki H, et al.
Ann Neurol
. 2022 Apr;
92(1):110-121.
PMID: 35428994
Objective: The motor severity in Parkinson disease (PD) is believed to parallel dopaminergic terminal degeneration in the striatum, although the terminal was reported to be virtually absent by 4 years...
7.
Kuboi T, Kusaka T, Okazaki K, Kaku U, Kakinuma R, Kondo M, et al.
Pediatr Int
. 2013 May;
55(2):e23-4.
PMID: 23679178
Hypoxic-ischemic encephalopathy in neonates causes irreversible damage to tissue and organs and results in multiple organ failure and poor outcome. Therapeutic hypothermia is the most effective therapy in neonates with...
8.
Inagaki T, Miyaoka T, Tsuji S, Inami Y, Nishida A, Horiguchi J
Prim Care Companion J Clin Psychiatry
. 2011 Apr;
12(6).
PMID: 21494350
Objective: Zolpidem, a nonbenzodiazepine hypnotic, is very effective and widely prescribed in clinical practice for the treatment of insomnia and is thought to have few adverse effects. However, zolpidem-induced adverse...
9.
Wake R, Miyaoka T, Tsuchie K, Kawakami K, Nishida A, Inagaki T, et al.
Aust N Z J Psychiatry
. 2009 Dec;
43(11):1057-69.
PMID: 20001401
Objective: The purpose of the present study was to examine whether patients with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome; GS) have specific changes in signal intensity on magnetic resonance imaging (MRI)....
10.
Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, et al.
Clin Neuropharmacol
. 2009 May;
32(1):6-9.
PMID: 19471183
Background: Recent studies indicate that the traditional Japanese herbal medicine yi-gan san (YGS; yokukan-san in Japanese) may be safe and useful in treating behavioral and psychological symptoms in patients with...